bicalutamide

Poland

Drugs containing this active substance

  • BICALUTAMIDE ACCORD

    This medicine is used in adult men to treat non-metastatic prostate cancer when castration or other treatment methods are not possible or cannot be used. It may also be used in combination with radiotherapy or surgery.

    Form: tablets, film-coated

    Active substance Dosage
    bicalutamide 150 mg

    ATC: L02BB03

    Manufacturer: Accord Healthcare Polska Limited Liability Company Accord Healthcare Single Member Corporation Laboratori Fundació Dau Pharmadox Healthcare Ltd.

  • BINABIC

    The medicine is used in the treatment of prostate cancer. It works by blocking male sex hormones, such as testosterone.

    Form: tablets, film-coated

    Active substance Dosage
    bicalutamide 50 mg

    ATC: L02BB03

    Manufacturer: Vipharm S.A.

  • BINABIC

    It is used in the treatment of prostate cancer. It works by blocking male sex hormones, such as testosterone.

    Form: tablets, film-coated

    Active substance Dosage
    bicalutamide 50 mg

    ATC: L02BB03

    Manufacturer: Vipharm S.A.

  • BINABIC

    The medicine is used in the treatment of prostate cancer. It works by blocking male sex hormones, such as testosterone.

    Form: tablets, film-coated

    Active substance Dosage
    bicalutamide 50 mg

    ATC: L02BB03

    Manufacturer: Vipharm S.A.